The Joint Blog

APRIL 17, 2020

This study summarizes potential adverse drug events related to THC when combined with other medications Medicinal Use of Marijuana Cannabis has been used widely across North America in various state or provincial medical marijuana programs. In 2018, ProCon.org has estimated well over 3.5M

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA has received adverse event reports involving delta-8 THC-containing products. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g., Adverse events included vomiting, hallucinations, trouble standing, and loss of consciousness. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

MARCH 17, 2022

Data Manager. The Data Manager, under the direction of the Director of Data Analytics, will be responsible for managing, manipulating, analyzing, and modeling data to support the Commission’s research agenda, licensing, and compliance decisions. Deadline to apply: March 31, 2022 by 5:00 p.m.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

SpeedWeed

APRIL 29, 2021

Curaleaf also hosts panel discussions and support events for all team members: . OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. PRIDE/QUSH (Queer-Centered Unity and Service Huddle). billion overall.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

JANUARY 13, 2020

In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. P1 (Brazil), and B.1.526

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

NOVEMBER 4, 2021

Hybrid Event Pairs In-Person Trade Show with Virtual Offerings through SupplySide Network 365 to Provide Opportunities for Innovation Professionals to Do Business. SupplySide Network 365 brought exciting advances and created new ways for industry members at the event and remote to connect and engage with show content.

Food 40

Food Events Supply Chain Business 40

Illinois News Joint

APRIL 2, 2023

To find more cannabis-friendly events in Illinois, visit here. The moneys shall be used to fund crime prevention programs, training, and interdiction efforts, including detection, enforcement, and prevention efforts, relating to the illegal cannabis market and driving under the influence of cannabis. (C)

Education 84

Education Cannabis Collective Programs 84

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 103

Marijuana Education Advocacy Legislation 103

SpeedWeed

APRIL 21, 2021

You cannot read a cannabis industry newsletter these days without seeing articles that hype the future impact of New York, New Jersey, Virginia, and New Mexico adult use programs. It even affects the stock prices of the Canadian licensed producers because the uninitiated believe these companies will benefit from new US programs.

Programs 52

Programs Dispensary Oil Cultivation 52

Cannabis Law Report

JUNE 2, 2021

Aggregate testing results will be reported to the director of the summer camp via safeCircle’s integration with CLEARED4, the Company’s pooled surveillance testing program partner, through CLEARED4’s smartphone-based online health safety management and reporting solution. Testing will be conducted from mid-June through end-July.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

MassRoots

AUGUST 4, 2020

We need SAFE Banking to ensure that BIPOC (Black, Indigenous, People of Color) owned businesses, especially women, have equitable access to funding and for the safety of our employees and our communities. However, even if the SBA were to set up a loan program, this could not be effectuated without access to banks. Washington, DC 20515.

Banking 52

Banking Access Business Programs 52

Cannabis Law Report

MARCH 19, 2020

2 At the conclusion of the meeting, FDA stated that it would form an internal working group to study data gaps relating to CBD. As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S. Net revenue.

Data 95

Data Vaping Supply Chain Business 95

SpeedWeed

FEBRUARY 19, 2021

We’re going to skip the data highlights today and dive right into our very special interview. In between seed-to-sale tracking, we collect upwards of 370 different unique events in the supply chain, that then the state agency has complete visibility into so that they can monitor for compliance. Amanda Guerrero: Hey, Ed.

Seed-To-Sale 52

Seed-To-Sale Environment Supply Chain Data 52

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. Sesen Bio remains committed to the health and safety of patients, caregivers and employees. About Sesen Bio. Sesen Bio, Inc. Cautionary Note on Forward-Looking Statements.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients.

Patients 98

Patients Education Marijuana Therapy 98

The Herb Collective

APRIL 29, 2019

While this does add more costs, it also ensures safety for users, which has to be a good thing. Increased Equity Licensing California’s final rules ensure that the BCC can focus more effectively on the implementation of its $10 equity grant program around the state’s cities and towns.

Law 45

Law Marijuana Banking Packaging 45

Cannabis Law Report

NOVEMBER 9, 2021

Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law. About LineaRx, Inc., For Applied DNA: Investor Contact: Sanjay M.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

CannaMD

DECEMBER 9, 2020

The AHA position paper then moves on to address a range of known, potential, and suggested safety concerns associated with cannabis use. The AHA statement raises questions on whether cannabis use plays a role in major cardiac events such as arrhythmia and heart attacks, but does not draw any definitive conclusions. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

SpeedWeed

APRIL 28, 2021

Curaleaf also hosts panel discussions and support events for all team members: . OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. PRIDE/QUSH (Queer-Centered Unity and Service Huddle). billion overall.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cultivation Food 52

SpeedWeed

APRIL 28, 2021

Curaleaf also hosts panel discussions and support events for all team members: . OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. PRIDE/QUSH (Queer-Centered Unity and Service Huddle). billion overall.

Legalization 52

Legalization Seed-To-Sale Dispensary Cannabis 52

SpeedWeed

APRIL 27, 2021

Curaleaf also hosts panel discussions and support events for all team members: . OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. PRIDE/QUSH (Queer-Centered Unity and Service Huddle). billion overall.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cannabis Cultivation 52

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. After this data has been entered, the information will be reviewed and you will receive your medical marijuana card. Note: New patient telehealth appointments remain illegal. Let us be blunt.

Law 126

Law Marijuana Patients Treatment 126

Peninsula Alternative Health

JUNE 12, 2023

This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. What impact does adult-use legalization have on the medical cannabis program? The new adult-use legislation does not directly affect the medical cannabis program in Maryland.

Legislation 52

Legislation Packaging Edibles Concentrates 52

Peninsula Alternative Health

JUNE 12, 2023

This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. What impact does adult-use legalization have on the medical cannabis program? The new adult-use legislation does not directly affect the medical cannabis program in Maryland.

Legislation 52

Legislation Packaging Edibles Concentrates 52

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

DECEMBER 20, 2021

Data To Support Regulatory Filings in the United States. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

NOVEMBER 5, 2021

Vaccinated participants in the safeCircle program are given a ‘blue pass.’ Hayward, president and CEO of Applied DNA, stated, “Employers are looking for an easy, customizable, and frictionless solution to help them meet all aspects of these new workplace safety and regulatory challenges.

Compliance 52

Compliance Compliance Research and Development Therapy 52

Puff Puff Post

NOVEMBER 5, 2019

Study #755-101-HV is a randomized, double-blind, vehicle-controlled, Phase 1 study designed to evaluate the local and systemic safety, tolerability, and pharmacokinetics of INM-755 cream applied daily on intact skin in healthy volunteers. Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. dollars in thousands (except for share and per share data). . . Fortified Balance Sheet.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

Cannabis Law Report

MAY 6, 2019

Risk management is the identification, evaluation, and prioritization of risks followed by coordinated and economical resources application which minimize, monitor, and control unfortunate events’ probability or impact. Department of Agriculture and Food and Drug Administration), state agencies (ex.,

Business 45

Business Marijuana Supply Chain Events 45